I was recently diagnosed with localized prostate cancer Gleason 8, which fortunately was caught early. After initial discussions with my healthcare team, I've begun hormone therapy, receiving my first injection about three to four weeks ago, along with a 28-day course of tablets. This decision came after extensive research, including information from the Prostate Cancer Research Institute.
During a recent consultation with a prostate cancer nurse, we discussed my treatment options in detail. The standard protocol involves hormone suppression for approximately 18 months, followed by 20 sessions of radiotherapy. We also explored alternative treatments, including a clinical trial offering a five-day radiotherapy regimen (currently paused but expected to resume in August) and brachytherapy, which involves inserting radioactive needles into the prostate gland for targeted radiation.
I inquired about the necessity of a PET scan, but the nurse explained that my imaging to date hasn't shown any enlarged lymph nodes of concern. As a result, further imaging wasn't recommended when my case was discussed at the multidisciplinary team meeting. This information reassured me about the localized nature of my cancer and the appropriateness of the proposed treatment options.
The oncolgist compared external radiation and brachytherapy, highlighting that brachytherapy offers more focused treatment with potentially fewer bowel side effects. We discussed practical aspects such as hospital stay duration and recovery time for each option.
For now, I'm continuing with the hormone therapy while I research and consult further. I've been provided with detailed information on both the clinical trial and brachytherapy to review at home. A follow-up appointment is scheduled to finalize my treatment plan.